Similar Articles
281 Novel prognostic factors after radical resection of hepatocellular carcinoma: Updating an old issue
282 Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention
283 Predictive value of NLR, Fib4, and APRI in the occurrence of liver failure after hepatectomy in patients with hepatocellular carcinoma
284 Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma
285 What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?
286 Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma
287 Comparative study between Embosphere® and Marine gel® as embolic agents for chemoembolization of hepatocellular carcinoma
288 C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients
289 Early gastric cancer recurrence after endoscopic submucosal dissection: Not to be ignored!
290 Peri-operative score for elderly patients with resectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA